Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2021 | 03-2021 | 01-2021 | 10-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,929 | 1,929 | 0 | 0 | 0 |
| Other current assets | 0 | 983 | 0 | 0 | 0 |
| TOTAL | $2,913 | $2,913 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,913 | $2,913 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 335 | 335 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 564 | 504 | 0 | 0 | 0 |
| Other current liabilities | N/A | 61 | 0 | 0 | 0 |
| TOTAL | $900 | $900 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $900 | $900 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 7 | 7 | 0 | 0 | 0 |
| Retained earnings | -16,832 | -16,832 | 0 | 0 | 0 |
| Other shareholders' equity | -14,883 | -14,883 | 0 | 0 | 0 |
| TOTAL | $2,013 | $2,013 | $0 | $0 | $0 |
| Total Liabilities And Equity | $2,913 | $2,913 | $0 | $0 | $0 |